The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastomaWantao Wu, Nan Zhang, Shuyu Li et al.|Heliyon|2023Cited by 25
A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapyHe Li, Ke Zhou, Kaiyue Wang et al.|Frontiers in Immunology|2022Cited by 10
A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancerHe Li, Renjun Peng, Jie Gu et al.|Frontiers in Immunology|2022Cited by 6
Competing Risk Model to Determine the Prognostic Factors and Treatment Strategies for Adult Patients with Malignant Meningioma: a SEER Population-Based StudyHe Li, Zhuoyi Liu, Jing Li et al.|Zenodo (CERN European Organization for Nuclear Research)|2023Cited by 0
Competing Risk Model to Determine the Prognostic Factors and Treatment Strategies for Adult Patients with Malignant Meningioma: a SEER Population-Based StudyHe Li, Zhuoyi Liu, Quan Cheng et al.|Zenodo (CERN European Organization for Nuclear Research)|2023Cited by 0